AXSM
Axsome Therapeutics, IncstockNASDAQ
Market OpenNov 17, 2026 10:27:49 AM EST
137.15USD+0.102%(+0.14)77,164
Pre-marketNov 17, 2026 9:27:30 AM EST
139.01USD+1.462%(+2.00)
AXSM Financials
In Q3 FY 2026 (ended ), Axsome Therapeutics, Inc (AXSM) reported revenue of $259.69M, net income of −$12.88M, operating cash flow of −$9.47M, and assets of $826.77M (filed ).
Loading financial statements…